The Children’s Cardiomyopathy Foundation (CCF) awards funds to support research related to all forms
of cardiomyopathy affecting children under the age of 18 years. The goal of CCF’s research program is
to advance medical knowledge on the disease and develop more accurate diagnostic methods, lifeimproving
therapies, and ultimately a cure.
The Children’s Cardiomyopathy Foundation (CCF) accepts grant proposals on an annual basis for
innovative basic, clinical or translational research relevant to the cause or treatment of cardiomyopathy in
children. CCF’s grant program is designed to provide seed funding to investigators for the testing of
initial hypotheses and collecting of preliminary data to help secure long-term funding by the National
Institute of Health (NIH) and other major granting institutions. Funding is available in the range of US
$25,000 - US $50,000 for total direct costs only. For grant renewals, CCF funding is limited to two years
(consecutive or otherwise) of support.
Grant award decisions are made through a careful and detailed peer-review selection process. Scientific
excellence and relevance to pediatric cardiomyopathy are the basic criteria for selecting supported
research projects. CCF will issue one request for proposals in 2009. The deadline for grant submission
is September 4, 2009 with final award decisions made by January 2010. Upon receipt of a signed letter
of agreement from the selected investigator, CCF will disburse the funds in installments during the grant
period.
Basic Requirements
The principal investigator must hold an MD, PhD or equivalent degree and reside in the United States or
Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian institution
and have the proven ability to pursue independent research as evidenced by original research publications
in peer-reviewed journals.
Tel: 866.808.CURE (2873)
Fax: 201.227.7016
E-mail: info@childrenscardiomyopathy.org
Mail: Children's Cardiomyopathy Foundation
P.O. Box 547
Tenafly, New Jersey 07670
U.S.A.
